株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

敗血症治療薬の世界市場 2019年~2023年

Global Sepsis Therapeutics Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 733586
出版日 ページ情報 英文 112 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.93円で換算しております。
Back to Top
敗血症治療薬の世界市場 2019年~2023年 Global Sepsis Therapeutics Market 2019-2023
出版日: 2018年10月18日 ページ情報: 英文 112 Pages
概要

敗血症について

敗血症は、微生物感染に対する人体の全身性炎症反応を指します。その結果、血流が損なわれ、器官が損傷します。抗生物質および昇圧剤は、敗血症の治療で最も一般的に使用される医薬品です。

Technavioのアナリストは、2019年から2023年にかけて世界の敗血症治療薬市場が5.41%のCAGRで成長すると予測しています。

当レポートでは、敗血症治療薬の世界市場について調査し、市場の概要、製品・地域別の市場規模の推移と予測、市場動向、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模の予測

第5章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • 市場状況

第6章 顧客情勢

第7章 市場セグメンテーション:製品別

  • 市場区分:製品別
  • 市場比較:製品別
  • 抗菌療法
  • アジュバント療法
  • 市場機会:製品別

第8章 地域情勢

  • 市場区分:地域別
  • 市場比較:地域別
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第11章 市場動向

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競合シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer

第14章 付録

  • 調査方法
  • 略語のリスト

第15章 Technavioについて

図表
  • Exhibit 01: Global infectious disease therapeutics market
  • Exhibit 02: Segments of global infectious disease therapeutics market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2018
  • Exhibit 06: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 07: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 08: Five forces analysis 2018
  • Exhibit 09: Five forces analysis 2023
  • Exhibit 10: Bargaining power of buyers
  • Exhibit 11: Bargaining power of suppliers
  • Exhibit 12: Threat of new entrants
  • Exhibit 13: Threat of substitutes
  • Exhibit 14: Threat of rivalry
  • Exhibit 15: Market condition - Five forces 2018
  • Exhibit 16: Product - Market share 2018-2023 (%)
  • Exhibit 17: Comparison by product
  • Exhibit 18: Antimicrobial therapy - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 19: Antimicrobial therapy - Year-over-year growth 2019-2023 (%)
  • Exhibit 20: Adjunctive therapy - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Adjunctive therapy - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Market opportunity by product
  • Exhibit 23: Market share by geography 2018-2023 (%)
  • Exhibit 24: Geographic comparison
  • Exhibit 25: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Top 3 countries in Americas
  • Exhibit 28: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Top 3 countries in EMEA
  • Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Top 3 countries in APAC
  • Exhibit 34: Market opportunity
  • Exhibit 35: Prevalence of sepsis in US
  • Exhibit 36: Impact of drivers and challenges
  • Exhibit 37: Vendor landscape
  • Exhibit 38: Landscape disruption
  • Exhibit 39: Vendors covered
  • Exhibit 40: Vendor classification
  • Exhibit 41: Market positioning of vendors
  • Exhibit 42: Akorn - Vendor overview
  • Exhibit 43: Akorn - Business segments
  • Exhibit 44: Akorn - Organizational developments
  • Exhibit 45: Akorn - Segment focus
  • Exhibit 46: Akorn - Key offerings
  • Exhibit 47: Akorn - Key customers
  • Exhibit 48: Baxter - Vendor overview
  • Exhibit 49: Baxter - Business segments
  • Exhibit 50: Baxter - Organizational developments
  • Exhibit 51: Baxter - Geographic focus
  • Exhibit 52: Baxter - Segment focus
  • Exhibit 53: Baxter - Key offerings
  • Exhibit 54: Baxter - Key customers
  • Exhibit 55: Fresenius - Vendor overview
  • Exhibit 56: Fresenius - Business segments
  • Exhibit 57: Fresenius - Organizational developments
  • Exhibit 58: Fresenius - Geographic focus
  • Exhibit 59: Fresenius - Segment focus
  • Exhibit 60: Fresenius - Key offerings
  • Exhibit 61: Fresenius - Key customers
  • Exhibit 62: Novartis - Vendor overview
  • Exhibit 63: Novartis - Business segments
  • Exhibit 64: Novartis - Organizational developments
  • Exhibit 65: Novartis - Geographic focus
  • Exhibit 66: Novartis - Segment focus
  • Exhibit 67: Novartis - Key offerings
  • Exhibit 68: Novartis - Key customers
  • Exhibit 69: Pfizer - Vendor overview
  • Exhibit 70: Pfizer - Business segments
  • Exhibit 71: Pfizer - Organizational developments
  • Exhibit 72: Pfizer - Geographic focus
  • Exhibit 73: Pfizer - Segment focus
  • Exhibit 74: Pfizer - Key offerings
  • Exhibit 75: Pfizer - Key customers
目次
Product Code: IRTNTR30047

About Sepsis

Sepsis refers to the human body's systemic inflammatory response to microbial infections. This results in impaired blood flow, which damages the organs. Antibiotics and vasopressors are the most commonly available medications for the treatment of sepsis.

Technavio's analysts forecast the Global Sepsis Therapeutics Market to grow at a CAGR of 5.41% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the sepsis therapeutics market. To calculate the market size, the report considers the revenue generated from the application of sepsis therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Sepsis Therapeutics Market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer

Market driver

  • High prevalence of sepsis
  • For a full, detailed list, view our report

Market challenge

  • Product withdrawals
  • For a full, detailed list, view our report

Market trend

  • Strategic alliances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Antimicrobial therapy - Market size and forecast 2018-2023
  • Adjunctive therapy - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer

PART 14: APPENDIX

  • Research methodolog
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

Back to Top